Spondyloarthropathies News

Although most patients with axial spondyolarthritis understand the importance of regular physical activity, few have the knowledge and skills necessary to perform cardiorespiratory training, according to data published in BMC Rheumatology.

Although ankylosing spondylitis correlates with higher rates of Alzheimer’s disease, patients who receive TNF inhibitors are less likely to develop the neurologic disorder, according to data published in Pharmacological Research.

In patients with spondyloarthritis, genetics and disease activity levels likely impact the composition of gut microbiota, according to data published in Arthritis & Rheumatology.

Although they exhibit a greater risk for severe immune-related adverse effects, patients with preexisting autoimmune disease receiving immune checkpoint inhibitors for melanoma had better 2-year survival than controls, according to data.

Upadacitinib is efficacious over 14 weeks in patients with ankylosing spondylitis who mounted poor responses to biologic disease-modifying antirheumatic drugs, according to data published in the Annals of the Rheumatic Diseases.

The FDA has approved a citrate-free, 100 mg/mL formulation of the Humira biosimilar Hadlima, according to a statement released by Samsung Bioepis and Organon.

Correctly identifying cytokine pathways that are dysregulated in any given rheumatology patient could lead to better use of current biologic therapies, said a presenter at the 2022 Association of Women in Rheumatology annual conference.

ORLANDO — Lifestyle modifications such as exercise and an anti-inflammatory diet can improve the well-being of patients being treated for autoimmune diseases, said a presenter at the 2022 Rheumatology Nurses Society Conference.

A citrate-free formulation of Taltz injection for patients is now available following its FDA approval earlier this year, Eli Lilly and Company announced in a press release.

ORLANDO, Fla. — Many patients with non-radiographic axial spondyloarthritis experience symptoms for nearly a decade before receiving a diagnosis, according to a presenter at the 2022 Rheumatology Nurses Society Conference.